Eagle Pharmaceuticals: Of This Current Report, Including Exhibit 99.1, Shall Not Be Deemed Filed For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended, Or The Exchange Act, Or Otherwise Subject To The Liabilities Of That Section, And Shall Not Be Deemed Incorporated By Reference Into Any Of The Company S Filings Under The Securities Act Of 1933, As Amended, Or The Exchange Act, Whether Made Before Or After The Date Hereof, Regardless Of Any General Incorporation Language In Such Filing, Except As Shall Be Expressly Set Forth By Specific Reference In Such Filing. The Furnishing Of The Information In This Current Report On Form 8k Is Not Intended To, And Does Not, Constitute A Determination Or Admission By The Company That The Information In This Current Report On Form 8k Is Material Or Complete, Or That Investors Should Consider This Information Before Making An Investment Decision With Respect To Any Security Of The Company, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Eagle Pharmaceuticals, Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***